Doxorubicin-induced cardiotoxicity.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  New England Journal of Medicine

• Publication date

  1995-11-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199511163332015PMID 7566043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variability in the pharmacokinetics of epirubicin: a population analysis

  2004cited by this paper
• Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

  1995cited by this paper
• Cardiac dysfunction following spinal irradiation during childhood.

  1993cited by this paper
• Cross‐reactivity between quinolones

  1993cited by this paper
• Increased risk of cardiac dysfunction after anthracyclines in girls.

  1993cited by this paper
• Fixed eruption caused by ciprofloxacin without cross‐sensitivity to norfloxacin

  1993cited by this paper
• Diminishment of Respiratory Sinus Arrhythmia Foreshadows Doxorubicin‐Induced Cardiomyopathy

  1991cited by this paper

• Protective effect of Baicalin against doxorubicin-induced cytotoxic and electrophysiological damage in human iPSC-cardiomyocytes

  2026cites this paper
• Pharmacological mechanisms of traditional Chinese medicine in treating gastric cancer: a focus on the ferroptosis regulation

  2026cites this paper
• Nanotechnology-driven synergy in cardio-oncology: enhancing tumor suppression and reducing cardiotoxicity

  2025cites this paper
• Mechanisms of circular RNAs in diabetic cardiomyopathy: biological characteristics and clinical prospects

  2025cites this paper
• Effect of astragaloside IV dripping pills on mice with dilated cardiomyopathy

  2025cites this paper
• Tetrahedral Framework Nucleic Acids Inhibit Oxidative Stress and Cardiomyocyte Apoptosis in Doxorubicin-Induced Cardiotoxicity

  2025cites this paper
• Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review)

  2025cites this paper
• Phytochemical Analysis and Protective Effect of Desmodium gyrans DC in Doxorubicin‐induced Cardiomyopathy and Isoproterenol‐induced Myocardial Infarction

  2025cites this paper
• Mechanism of Cardiac Energy Metabolism Disturbance Induced by EC-T Sequential Chemotherapy After Breast Conserving Surgery in Stage I–II Breast Cancer Patients: A Prospective Cohort Study

  2025cites this paper
• Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα–mTORC1 signaling pathway

  2024cites this paper
• Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution

  2024cites this paper
• Establishment of a novel microfluidic co-culture system for simultaneous analysis of multiple indicators of gefitinib sensitivity in colorectal cancer cells

  2024cites this paper
• Biomarkers of chemotherapy-induced cardiotoxicity: toward precision prevention using extracellular vesicles

  2024cites this paper
• Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis

  2024cites this paper
• Discovery of New D‐Ring Modified Isosteviol Derivatives as Potent Cardioprotective Agents against Oxidative Stress‐Trigged Damage

  2023cites this paper
• Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes

  2023cites this paper
• Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure

  2023cites this paper
• Hypophyllanthin and Phyllanthin from Phyllanthus niruri Synergize Doxorubicin Anticancer Properties against Resistant Breast Cancer Cells

  2023cites this paper
• Leucine zipper protein 1 prevents doxorubicin-induced cardiotoxicity in mice

  2023cites this paper
• IRG1 Prevents Excessive Inflammatory Responses and Cardiac Dysfunction after Myocardial Injury.

  2023cites this paper
• Nanomicelles co-loaded with doxorubicin and salvianolic acid A for breast cancer chemotherapy

  2022cites this paper
• Citalopram Induced Cardiotoxicity in Rats at Repeated Doses

  2022cites this paper
• Doxorubicin-Induced Cardiotoxicity: Mechanisms and Management

  2022cites this paper
• PHLPP1 deficiency ameliorates cardiomyocyte death and cardiac dysfunction through inhibiting Mcl-1 degradation.

  2022cites this paper
• Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A

  2021cites this paper
• The role of interleukin-10 family members in cardiovascular diseases.

  2021cites this paper
• The Effects of Inhibition of MicroRNA-375 in a Mouse Model of Doxorubicin-Induced Cardiac Toxicity

  2020cites this paper
• Regulatory Mechanisms of Sesn2 and its Role in Multi-organ Diseases.

  2020cites this paper
• Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice

  2020cites this paper
• Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin‐induced cardiotoxicity

  2020cites this paper
• Young at Heart: Combining Strategies to Rejuvenate Endogenous Mechanisms of Cardiac Repair

  2020cites this paper
• MicroRNA-143 Increases Oxidative Stress and Myocardial Cell Apoptosis in a Mouse Model of Doxorubicin-Induced Cardiac Toxicity

  2020cites this paper
• Epigallocatechin-3-gallate inhibits doxorubicin-induced inflammation on human ovarian tissue

  2019cites this paper
• Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity

  2019cites this paper
• In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate

  2019cites this paper
• Curdione Ameliorated Doxorubicin-Induced Cardiotoxicity Through Suppressing Oxidative Stress and Activating Nrf2/HO-1 pathway.

  2019cites this paper
• FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT

  2019cites this paper
• Nephroprotective effect of Costus pictus extract against doxorubicin-induced toxicity on Wistar rat

  2019cites this paper
• Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment.

  2019cites this paper
• Heart Tissue Changes Following Doxorubicin Toxicity: An Experimental Study on the Protective Effect of Aerobic Training in Young and Old Rats

  2018cites this paper
• Downregulation of CUEDC2 prevents doxorubicin-induced cardiotoxicity in H9c2 cells

  2018influential citation
• A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish.

  2018cites this paper
• Ameliorating the anticancer drug ”Adriamycin” acute Cardiotoxicity by Rosuvastatin and Telmisartan in rats

  2018cites this paper
• Nanoceria-mediated delivery of doxorubicin enhances the anti-tumour efficiency in ovarian cancer cells via apoptosis

  2017cites this paper
• Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors.

  2017cites this paper
• Reversal of Doxorubicin-induced Cardiotoxicity by Using Phytotherapy: A Review

  2017cites this paper
• Hypolipidemic and Antioxidative Effects of African Star Apple Juice ( Chrysophylum albidum ) on Rats Fed on Diets High in Cholesterol and Oil

  2016cites this paper
• Subclinical Cardiovascular Disease in Lymphoma Survivors by Sex.

  2016cites this paper
• Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems.

  2016cites this paper
• Age-Related Changes in Doxorubicin-Induced Oxidative Damage: Protective and Pretreatment Effects of Short-Term Aerobic Exercise

  2016cites this paper
• SIRT1 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the Oxidative Stress and p38MAPK Pathways

  2015cites this paper
• Silencing NOB 1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo

  2015cites this paper
• Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation

  2015cites this paper
• Ophiopogonin D Attenuates Doxorubicin-Induced Autophagic Cell Death by Relieving Mitochondrial Damage In Vitro and In Vivo

  2015cites this paper
• Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo.

  2015cites this paper
• Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo

  2015cites this paper
• Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice

  2014influential citation
• Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi‐1 expression

  2014cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for managing peritoneal carcinomatosis from endometrial carcinoma: a single-center experience of 6 cases

  2014cites this paper
• Caspase Mediated Synergistic Effect of Boswellia serrata Extract in Combination with Doxorubicin against Human Hepatocellular Carcinoma

  2014cites this paper
• Asetil L-karnitin ve doksorubisinin rat çizgili kasi üzerine etkilerinin araştirilmasi Investigation of the effects of Acetyl L-carnitine and doxorubicin on rats' striated muscle

  2013cites this paper
• Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review.

  2012cites this paper
• Protective effects of berberine on doxorubicin-induced nephrotoxicity in mice

  2012cites this paper
• Influência do Reparo por Excisão de Nucleotídeos na Citotoxicidade do Antineoplásico Mitoxantrona

  2012cites this paper
• Protective effects of berberine on doxorubicin-induced nephrotoxicity in mice

  2012cites this paper
• Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl

  2012cites this paper
• Review of Cardiotoxicity in Pediatric Cancer Patients: During and after Therapy

  2011cites this paper
• Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK.

  2011cites this paper
• Berberine Attenuates Doxorubicin-Induced Cardiotoxicity in Mice

  2011cites this paper
• Protective effect of Syzygium cumini seeds against doxorubicin induced cardiotoxicity in rats

  2010cites this paper
• Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin.

  2009cites this paper
• The molecular mechanisms of iron and ferritin metabolism in.

  2008cites this paper
• Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin-induced toxicity in cardiomyocytes.

  2008cites this paper
• A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline

  2008cites this paper
• Early Diagnosis of Chemotherapy-induced Cardiomyopathy: a Prospective Tissue Doppler Imaging Study

  2008cites this paper
• Hexane/Ethanol Extract of Glycyrrhiza uralensis Licorice Suppresses Doxorubicin-Induced Apoptosis in H9c2 Rat Cardiac Myoblasts

  2008cites this paper
• Cannabinoid receptors in acute and chronic complications of atherosclerosis

  2008cites this paper
• Aristolochic Acid induces heart failure in zebrafish embryos that is mediated by inflammation.

  2007cites this paper
• Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.

  2007cites this paper
• Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.

  2005cites this paper
• Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.

  2004cites this paper
• Cardiac safety of liposomal anthracyclines.

  2004cites this paper
• A comparative pharmacokinetic study of doxorubicin and 4′-epi-doxorubicin in children with acute lymphocytic leukemia using a limited sampling procedure

  2000cites this paper
• Applications of liposome technology in modulating p-glycoprotein mediated multidrug resistance

  1999cites this paper
• The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein‐1 in cytosolic fractions from human myocardium

  1998cites this paper
• Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.

  1996cites this paper
• Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.

  1995cites this paper